Mild parenchymal lung disease is still lung disease
Laurent Godinas, Sergio Harari, Joan A. Barberà, David Montani
European Respiratory Journal 2020 56: 2003542; DOI: 10.1183/13993003.03542-2020
Laurent Godinas
1Dept of Respiratory Diseases, UZ Leuven, Campus Gasthuisberg, Leuven, Belgium
2Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Dept CHROMETA, KU Leuven, Leuven, Belgium
Sergio Harari
3Dept of Clinical Sciences and Community Health, University of Milan, Milan, Italy
4Dept of Medical Sciences, Ospedale San Giuseppe, MultiMedica IRCCS, Milan, Italy
Joan A. Barberà
5Respiratory Institute, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute, University of Barcelona, Barcelona, Spain
David Montani
6Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France
7Assistance Publique - Hôpitaux de Paris (AP-HP), Dept of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
8INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, France
Vol 56 Issue 5
Table of Contents
Mild parenchymal lung disease is still lung disease
Laurent Godinas, Sergio Harari, Joan A. Barberà, David Montani
European Respiratory Journal Nov 2020, 56 (5) 2003542; DOI: 10.1183/13993003.03542-2020